FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cilnidipine 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely methylergometrine maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely methylergometrine maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lornoxicam 16 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lornoxicam 16 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely eslicarbazepine acetate 600 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely eslicarbazepine acetate 600 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aceclofenac 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aceclofenac 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aceclofenac 100 milligram and thiocolchicoside 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aceclofenac 100 milligram and thiocolchicoside 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aceclofenac 100 milligram and thiocolchicoside 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely domperidone 10 milligram and pantoprazole (as pantoprazole sodium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely domperidone 10 milligram and pantoprazole (as pantoprazole sodium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely domperidone 10 milligram and pantoprazole (as pantoprazole sodium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely imipramine hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely imipramine hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlortalidone 25 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ramipril 5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely eletriptan (as eletriptan hydrobromide) 20 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely clopidogrel bisulfate 75 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely celiprolol hydrochloride 200 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 20 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dydrogesterone 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely glipizide 2.5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely varenicline 500 microgram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely saquinavir 500 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely labetalol hydrochloride 100 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely telmisartan 80 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely methocarbamol 750 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely tolbutamide 500 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely pimozide 2 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely senna 15 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely levonorgestrel 1.5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dipyridamole 25 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely codeine phosphate 15 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely temazepam 20 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ciprofibrate 100 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely flutamide 250 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely protriptyline hydrochloride 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefprozil 500 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely gabapentin 600 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely ezetimibe 10 milligram and simvastatin 20 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely terfenadine 60 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely isradipine 2.5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely metoclopramide hydrochloride 10 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely entacapone 200 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely mefenamic acid 500 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely colesevelam hydrochloride 625 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely amisulpride 200 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier

Start Previous Page 81 of 153 Next End


This concept is not in any reference sets

Back to Start